Opinion
Video
Author(s):
Faculty provide insights into the selection of BTK inhibitors, emphasizing the role of efficacy, toxicity, and quality of life data in treatment decisions, and exploring the impact of MAIC data.
NCCN Updates ctDNA Stance in Colon, Rectal, and MCC Guidelines
FDA Grants Fast Track Designation to CUSP06 for Platinum-Resistant Ovarian Cancer
Potential Applications of Cancer Vaccines Continue to Expand in Squamous Cell Carcinoma
FDA Approves Brentuximab Vedotin Plus Lenalidomide/Rituximab for R/R LBCL
2 Commerce Drive
Cranbury, NJ 08512